
Investors Face September Deadline in Procept Biorobotics Class Action
Investors in Procept Biorobotics Corporation have until September 22, 2026, to apply for lead plaintiff status in a pending securities class action. The lawsuit alleges the medical technology firm masked significant inventory imbalances by misrepresenting the relationship between handpiece sales and actual clinical procedure volumes.




















